HAE
Haemonetics CorpNYSE
1d
5d
1m
6m
1y
5y
10y
Advanced Chart
  • Sep. 18, 2012, 2:02 PM

    Haemonetics (HAE -0.4%) says its proposed acquisition of Hemerus Medical will likely be put off until next March after the start of its 2014 fiscal year. The company notes that U.S. regulators are asking for more information about its SOLX whole-blood collection system as part of a resubmitted marketing application.

    | Sep. 18, 2012, 2:02 PM
  • Apr. 30, 2012, 3:24 AM

    Pall Corp (PLL) said yesterday it will sell some of its blood collection, filtration and processing product lines to Haemonetics Corp (HAE) for ~$550M. Separately, Haemonetics announced it will acquire the business assets of Hemerus Medical, a company that develops innovative blood technologies.

    | Apr. 30, 2012, 3:24 AM